APS vs. PDP, COV, HBP, EMH, PMN, DMT, MBX, IBT, BCT, and ACST
Should you be buying Aptose Biosciences stock or one of its competitors? The main competitors of Aptose Biosciences include Pediapharm (PDP), Covalon Technologies (COV), Helix BioPharma (HBP), Emerald Health Therapeutics (EMH), ProMIS Neurosciences (PMN), Small Pharma (DMT), Microbix Biosystems (MBX), IBEX Technologies (IBT), BriaCell Therapeutics (BCT), and Acasti Pharma (ACST). These companies are all part of the "biotechnology" industry.
Aptose Biosciences (TSE:APS) and Pediapharm (CVE:PDP) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, community ranking, dividends, profitability and media sentiment.
Aptose Biosciences received 147 more outperform votes than Pediapharm when rated by MarketBeat users. Likewise, 72.11% of users gave Aptose Biosciences an outperform vote while only 67.71% of users gave Pediapharm an outperform vote.
Pediapharm's return on equity of 0.00% beat Aptose Biosciences' return on equity.
In the previous week, Aptose Biosciences had 4 more articles in the media than Pediapharm. MarketBeat recorded 4 mentions for Aptose Biosciences and 0 mentions for Pediapharm. Aptose Biosciences' average media sentiment score of 0.92 beat Pediapharm's score of 0.00 indicating that Aptose Biosciences is being referred to more favorably in the media.
Pediapharm has higher revenue and earnings than Aptose Biosciences. Pediapharm is trading at a lower price-to-earnings ratio than Aptose Biosciences, indicating that it is currently the more affordable of the two stocks.
7.5% of Aptose Biosciences shares are held by institutional investors. 19.1% of Aptose Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Aptose Biosciences beats Pediapharm on 7 of the 12 factors compared between the two stocks.
Get Aptose Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aptose Biosciences Competitors List
Related Companies and Tools
